These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 20100960)

  • 41. Hormone receptor status of a first primary breast cancer predicts contralateral breast cancer risk in the WECARE study population.
    Reiner AS; Lynch CF; Sisti JS; John EM; Brooks JD; Bernstein L; Knight JA; Hsu L; Concannon P; Mellemkjær L; Tischkowitz M; Haile RW; Shen R; Malone KE; Woods M; Liang X; Morrow M; Bernstein JL;
    Breast Cancer Res; 2017 Jul; 19(1):83. PubMed ID: 28724391
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Statins and breast cancer in postmenopausal women without hormone therapy.
    Eaton M; Eklof J; Beal JR; Sahmoun AE
    Anticancer Res; 2009 Dec; 29(12):5143-8. PubMed ID: 20044629
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Association of hormone replacement therapy to estrogen and progesterone receptor status in invasive breast carcinoma.
    Chen WY; Hankinson SE; Schnitt SJ; Rosner BA; Holmes MD; Colditz GA
    Cancer; 2004 Oct; 101(7):1490-500. PubMed ID: 15378477
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Postmenopausal obesity as a breast cancer risk factor according to estrogen and progesterone receptor status (Japan).
    Yoo K; Tajima K; Park S; Kang D; Kim S; Hirose K; Takeuchi T; Miura S
    Cancer Lett; 2001 Jun; 167(1):57-63. PubMed ID: 11323099
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Association Between Migraine and Breast Cancer Risk: A Population-Based Cohort Study and Literature Review.
    Fan CY; Lin CS; Huang WY; Lin KT; Chao HL; Tsao CC; Liu MY; Tsai IJ; Kao CH
    J Womens Health (Larchmt); 2018 Dec; 27(12):1499-1507. PubMed ID: 30183462
    [No Abstract]   [Full Text] [Related]  

  • 46. The efficacy of sequential second-line endocrine therapies (ETs) in postmenopausal estrogen receptor-positive and HER2-negative metastatic breast cancer patients with lower sensitivity to initial ETs.
    Iwamoto T; Fujisawa T; Shien T; Araki K; Sakamaki K; Sangai T; Kikawa Y; Takao S; Nishimura R; Takahashi M; Aihara T; Mukai H; Taira N
    Breast Cancer; 2020 Sep; 27(5):973-981. PubMed ID: 32394413
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Expression of estrogen and progesterone receptors in human ductal invasive breast carcinoma not otherwise specified: is there any difference between premenopausal and postmenopausal women?
    Petricević J; Petković M; Jonjić N
    Acta Clin Croat; 2011 Jun; 50(2):169-75. PubMed ID: 22263379
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Non-steroidal anti-inflammatory drug use, hormone receptor status, and breast cancer-specific mortality in the Carolina Breast Cancer Study.
    Allott EH; Tse CK; Olshan AF; Carey LA; Moorman PG; Troester MA
    Breast Cancer Res Treat; 2014 Sep; 147(2):415-21. PubMed ID: 25151293
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Migraine and possible etiologic heterogeneity for hormone-receptor-negative breast cancer.
    Shi M; DeRoo LA; Sandler DP; Weinberg CR
    Sci Rep; 2015 Oct; 5():14943. PubMed ID: 26456840
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Migraine and breast cancer risk: a prospective cohort study and meta-analysis.
    Winter AC; Rice MS; Fortner RT; Eliassen AH; Kurth T; Tamimi RM
    J Natl Cancer Inst; 2015 Jan; 107(1):381. PubMed ID: 25505231
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Association of frequency and duration of aspirin use and hormone receptor status with breast cancer risk.
    Terry MB; Gammon MD; Zhang FF; Tawfik H; Teitelbaum SL; Britton JA; Subbaramaiah K; Dannenberg AJ; Neugut AI
    JAMA; 2004 May; 291(20):2433-40. PubMed ID: 15161893
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hormonal factors and the risk of breast cancer according to estrogen- and progesterone-receptor subgroup.
    Cotterchio M; Kreiger N; Theis B; Sloan M; Bahl S
    Cancer Epidemiol Biomarkers Prev; 2003 Oct; 12(10):1053-60. PubMed ID: 14578142
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinicopathological Characteristics and Breast Cancer-Specific Survival of Patients With Single Hormone Receptor-Positive Breast Cancer.
    Li Y; Yang D; Yin X; Zhang X; Huang J; Wu Y; Wang M; Yi Z; Li H; Li H; Ren G
    JAMA Netw Open; 2020 Jan; 3(1):e1918160. PubMed ID: 31899528
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Relationship between migraine history and breast cancer risk among premenopausal and postmenopausal women.
    Li CI; Mathes RW; Malone KE; Daling JR; Bernstein L; Marchbanks PA; Strom BL; Simon MS; Press MF; Deapen D; Burkman RT; Folger SG; McDonald JA; Spirtas R
    Cancer Epidemiol Biomarkers Prev; 2009 Jul; 18(7):2030-4. PubMed ID: 19589913
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hip circumference is associated with the risk of premenopausal ER-/PR- breast cancer.
    Fagherazzi G; Chabbert-Buffet N; Fabre A; Guillas G; Boutron-Ruault MC; Mesrine S; Clavel-Chapelon F
    Int J Obes (Lond); 2012 Mar; 36(3):431-9. PubMed ID: 21427693
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lapatinib combined with letrozole versus letrozole and placebo as first-line therapy for postmenopausal hormone receptor-positive metastatic breast cancer.
    Johnston S; Pippen J; Pivot X; Lichinitser M; Sadeghi S; Dieras V; Gomez HL; Romieu G; Manikhas A; Kennedy MJ; Press MF; Maltzman J; Florance A; O'Rourke L; Oliva C; Stein S; Pegram M
    J Clin Oncol; 2009 Nov; 27(33):5538-46. PubMed ID: 19786658
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Height, sitting height, and leg length in relation with breast cancer risk in the E3N cohort.
    Fagherazzi G; Vilier A; Boutron-Ruault MC; Clavel-Chapelon F; Mesrine S
    Cancer Epidemiol Biomarkers Prev; 2012 Jul; 21(7):1171-5. PubMed ID: 22623708
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Periodontal Disease and Breast Cancer: Prospective Cohort Study of Postmenopausal Women.
    Freudenheim JL; Genco RJ; LaMonte MJ; Millen AE; Hovey KM; Mai X; Nwizu N; Andrews CA; Wactawski-Wende J
    Cancer Epidemiol Biomarkers Prev; 2016 Jan; 25(1):43-50. PubMed ID: 26689418
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Steroid receptor status and its clinicopathological correlation in post-menopausal breast cancer patients of Kumaon region of Uttarakhand.
    Shahi KS; Bhandari G; Singh A
    J Cancer Res Ther; 2011; 7(1):19-22. PubMed ID: 21546737
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nonsteroidal anti-inflammatory drugs and the risk of developing breast cancer in a population-based prospective cohort study in Washington County, MD.
    Gallicchio L; Visvanathan K; Burke A; Hoffman SC; Helzlsouer KJ
    Int J Cancer; 2007 Jul; 121(1):211-15. PubMed ID: 17330846
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.